Biomanufacturing for a Sustainable Future: Unleashing the Potential of Biotechnology in Pharmaceutical Raw Material Production
DOI:
https://doi.org/10.63053/ijhes.81Keywords:
Pharmaceutical raw materials, Recombinant DNA technology, Microbial fermentation, Biocatalysis, Cell culture technologyAbstract
The pharmaceutical industry relies heavily on raw materials for drug development, with Active Pharmaceutical Ingredients (APIs) and excipients forming the fundamental components of pharmaceutical formulations. Traditional methods of pharmaceutical raw material production are plagued by inefficiencies, environmental concerns, and limitations in producing complex molecules. In contrast, biotechnology offers a promising alternative with its capacity for efficient, sustainable, and precise synthesis of pharmaceutical raw materials. This article explores the potential of biotechnology in pharmaceutical raw material production, focusing on techniques such as recombinant DNA technology, microbial fermentation, biocatalysis, and cell culture technology. These methods enable the production of complex molecules with high specificity, purity, and scalability, addressing the shortcomings of traditional approaches. Furthermore, biotechnology facilitates the development of novel drugs, personalized medicine strategies, and innovative treatments, offering hope for previously untreatable conditions. Despite the transformative potential of biotechnology, challenges such as high initial investment, regulatory considerations, and safety concerns need to be addressed for its widespread adoption. In conclusion, embracing biotechnology represents a paradigm shift in pharmaceutical production, promising a more sustainable, personalized, and effective healthcare future. Collaboration between stakeholders is essential to navigate challenges and ensure the responsible advancement of biotechnological applications in healthcare, ultimately improving the quality of life for millions worldwide
References
Kh, Ulaan-Od, and Baoyintu Bai. "The study regarding pharmaceutical raw material of animal derived medicine in “Ocean of medicine names”." Mongolian Medical Sciences (2022): 33-37.
Bharate, Sonali S., Sandip B. Bharate, and Amrita N. Bajaj. "Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review." Journal of Excipients and Food Chemicals 1.3 (2016).
Lu, Jie, and Sohrab Rohani. "Polymorphism and crystallization of active pharmaceutical ingredients (APIs)." Current Medicinal Chemistry 16.7 (2009): 884-905. DOI: https://doi.org/10.2174/092986709787549299
Chaudhari, Shilpa P., and Pradeep S. Patil. "Pharmaceutical excipients: a review." Int J Adv Pharm Biol Chem 1.1 (2012): 21-34.
Phillips, Daniel J., et al. "Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems." Journal of Pharmacy and Pharmacology 64.11 (2012): 1549-1559. DOI: https://doi.org/10.1111/j.2042-7158.2012.01523.x
Castiello, Carola, et al. "GreenMedChem: the challenge in the next decade toward eco-friendly compounds and processes in drug design." Green Chemistry 25.6 (2023): 2109-2169. DOI: https://doi.org/10.1039/D2GC03772F
Sethi, Nilay, and Yibin Kang. "Unravelling the complexity of metastasis—molecular understanding and targeted therapies." Nature Reviews Cancer 11.10 (2011): 735-748. DOI: https://doi.org/10.1038/nrc3125
Gurnani, N., et al. "Natural products: source of potential drugs." Afr J Basic Appl Sci 6.6 (2014): 171-186.
Salgueiro, L., A. P. Martins, and H. Correia. "Raw materials: the importance of quality and safety. A review." Flavour and Fragrance Journal 25.5 (2010): 253-271. DOI: https://doi.org/10.1002/ffj.1973
Gavrilescu, Maria, and Yusuf Chisti. "Biotechnology—a sustainable alternative for chemical industry." Biotechnology advances 23.7-8 (2005): 471-499. DOI: https://doi.org/10.1016/j.biotechadv.2005.03.004
Walsh, Gary. "Pharmaceutical biotechnology: concepts and applications." (2007).
Schulman, Kevin A., K. Robin Yabroff, and Henry Glick. "A health services approach for the evaluation of innovative pharmaceutical and biotechnology products." Drug information journal 29.4 (1995): 1405-1414. DOI: https://doi.org/10.1177/009286159502900446
Kumara Behera, Basanta, et al. "Microbial Products Supply Chain." Microbial Biomass Process Technologies and Management (2017): 215-255. DOI: https://doi.org/10.1007/978-3-319-53913-3_4
Khan, Suliman, et al. "Role of recombinant DNA technology to improve life." International journal of genomics 2016 (2016). DOI: https://doi.org/10.1155/2016/2405954
Johnson, Irving S. "Human insulin from recombinant DNA technology." Science 219.4585 (1983): 632-637. DOI: https://doi.org/10.1126/science.6337396
Salomon, Franco, et al. "The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency." New England Journal of Medicine 321.26 (1989): 1797-1803. DOI: https://doi.org/10.1056/NEJM198912283212605
Rowell, Frederick J., and JAMES R. FURR. "Recombinant DNA technology: monoclonal antibodies." Smith and Williams' Introduction to the Principles of Drug Design and Action. CRC Press, 2019. 491-508. DOI: https://doi.org/10.1201/9781315273792-12
Hill, Daragh, et al. "Recent advances in microbial fermentation for dairy and health." F1000Research 6 (2017). DOI: https://doi.org/10.12688/f1000research.10896.1
Hook, Derek J. "Production of antibiotics by fermentation." Basic Biotechnology (2006): 433. DOI: https://doi.org/10.1017/CBO9780511802409.020
Survase, Shrikant A., Ishwar B. Bajaj, and Rekha S. Singhal. "Biotechnological Production of Vitamins." Food Technology & Biotechnology 44.3 (2006).
Vittaladevaram, Viswanath. "Fermentative Production of Microbial Enzymes and their Applications: Present status and future prospects." Journal of Applied Biology and Biotechnology 5.4 (2017): 090-094.
D'Este, Martina, Merlin Alvarado-Morales, and Irini Angelidaki. "Amino acids production focusing on fermentation technologies–A review." Biotechnology advances 36.1 (2018): 14-25. DOI: https://doi.org/10.1016/j.biotechadv.2017.09.001
Ivanov, Kalin, et al. "Biotechnology in the production of pharmaceutical industry ingredients: amino acids." Biotechnology & Biotechnological Equipment 27.2 (2013): 3620-3626. DOI: https://doi.org/10.5504/BBEQ.2012.0134
Bell, Elizabeth L., et al. "Biocatalysis." Nature Reviews Methods Primers 1.1 (2021): 46. DOI: https://doi.org/10.1038/s43586-021-00044-z
Hoyos, Pilar, Vittorio Pace, and Andrés R. Alcántara. "Biocatalyzed synthesis of statins: A sustainable strategy for the preparation of valuable drugs." Catalysts 9.3 (2019): 260. DOI: https://doi.org/10.3390/catal9030260
Wegman, Margreth A., et al. "Towards biocatalytic synthesis of β‐lactam antibiotics." Advanced Synthesis & Catalysis 343.6‐7 (2001): 559-576. DOI: https://doi.org/10.1002/1615-4169(200108)343:6/7<559::AID-ADSC559>3.0.CO;2-Z
Veronese, Francesco M., and Anna Mero. "The impact of PEGylation on biological therapies." BioDrugs 22 (2008): 315-329. DOI: https://doi.org/10.2165/00063030-200822050-00004
Ozturk, Sadettin, and Wei-Shou Hu, eds. Cell culture technology for pharmaceutical and cell-based therapies. CRC press, 2005. DOI: https://doi.org/10.1201/9780849351068
Rappuoli, Rino. "Cell-culture-based vaccine production: technological options." BRIDGE-WASHINGTON-NATIONAL ACADEMY OF ENGINEERING- 36.3 (2006): 25.
Li, Feng, et al. "Cell culture processes for monoclonal antibody production." MAbs. Vol. 2. No. 5. Taylor & Francis, 2010. DOI: https://doi.org/10.4161/mabs.2.5.12720
Caplan, Arnold I. "Mesenchymal stem cells and gene therapy." Clinical Orthopaedics and Related Research (1976-2007) 379 (2000): S67-S70. DOI: https://doi.org/10.1097/00003086-200010001-00010
Soetaert, Wim, and Erick Vandamme. "The impact of industrial biotechnology." Biotechnology Journal: Healthcare Nutrition Technology 1.7‐8 (2006): 756-769. DOI: https://doi.org/10.1002/biot.200600066
Wohlgemuth, Roland. "The locks and keys to industrial biotechnology." New Biotechnology 25.4 (2009): 204-213. DOI: https://doi.org/10.1016/j.nbt.2009.01.002
Demling, Philipp, et al. "Quantitative measurements in single-cell analysis: towards scalability in microbial bioprocess development." Current opinion in biotechnology 54 (2018): 121-127. DOI: https://doi.org/10.1016/j.copbio.2018.01.024
Conner, John, et al. "The biomanufacturing of biotechnology products." Biotechnology entrepreneurship. Academic Press, 2014. 351-385. DOI: https://doi.org/10.1016/B978-0-12-404730-3.00026-9
Aggarwal, Saurabh. "Targeted cancer therapies." Nature reviews. Drug discovery 9.6 (2010): 427. DOI: https://doi.org/10.1038/nrd3186
Tang, Lisa, et al. "Pharmacokinetic aspects of biotechnology products." Journal of pharmaceutical sciences 93.9 (2004): 2184-2204. DOI: https://doi.org/10.1002/jps.20125
Neubauer, Peter, et al. "Consistent development of bioprocesses from microliter cultures to the industrial scale." Engineering in Life Sciences 13.3 (2013): 224-238. DOI: https://doi.org/10.1002/elsc.201200021
Tibbetts, John H. "Synthetic Biology and Endangered Species: Should scientists genetically rewire nature to save species and habitats?." BioScience 72.7 (2022): 610-617. DOI: https://doi.org/10.1093/biosci/biac040
Manole-Paunescu, Anca. "Biotechnology for endangered plant conservation." Biotechnology and Biodiversity (2014): 181-202. DOI: https://doi.org/10.1007/978-3-319-09381-9_10
Liu, Chunzhao, Yan Zhao, and Yuchun Wang. "Artemisinin: current state and perspectives for biotechnological production of an antimalarial drug." Applied microbiology and biotechnology 72 (2006): 11-20. DOI: https://doi.org/10.1007/s00253-006-0452-0
Vendrely, Charlotte, and Thomas Scheibel. "Biotechnological production of spider‐silk proteins enables new applications." Macromolecular bioscience 7.4 (2007): 401-409. DOI: https://doi.org/10.1002/mabi.200600255
Duelen, Robin, et al. "Medicinal biotechnology for disease modeling, clinical therapy, and drug discovery and development." Introduction to Biotech Entrepreneurship: From Idea to Business: A European Perspective (2019): 89-128. DOI: https://doi.org/10.1007/978-3-030-22141-6_5
Salfeld, Jochen G. "Use of new biotechnology to design rational drugs against newly defined targets." Best Practice & Research Clinical Rheumatology 18.1 (2004): 81-95. DOI: https://doi.org/10.1016/j.berh.2003.10.001
Zeng, Weizhu, et al. "High-throughput screening technology in industrial biotechnology." Trends in biotechnology 38.8 (2020): 888-906. DOI: https://doi.org/10.1016/j.tibtech.2020.01.001
Ma, Cui-Cui, et al. "The approved gene therapy drugs worldwide: from 1998 to 2019." Biotechnology advances 40 (2020): 107502. DOI: https://doi.org/10.1016/j.biotechadv.2019.107502
Riley, Rachel S., et al. "Delivery technologies for cancer immunotherapy." Nature reviews Drug discovery 18.3 (2019): 175-196. DOI: https://doi.org/10.1038/s41573-018-0006-z
Fasim, Aneesa, Veena S. More, and Sunil S. More. "Large-scale production of enzymes for biotechnology uses." Current opinion in biotechnology 69 (2021): 68-76. DOI: https://doi.org/10.1016/j.copbio.2020.12.002
Rathore, Anurag S., Deepak Kumar, and Nikhil Kateja. "Role of raw materials in biopharmaceutical manufacturing: risk analysis and fingerprinting." Current opinion in biotechnology 53 (2018): 99-105. DOI: https://doi.org/10.1016/j.copbio.2017.12.022
Broeze, Robert J. "Key challenges facing bio manufacturing." Bioprocessing and Biopartnering 2006 (2006): 14-16.
Kitney, Richard I. "Building the UK's industrial base in engineering biology." Engineering Biology 5.4 (2021): 98-106. DOI: https://doi.org/10.1049/enb2.12016
Gargalo, Carina L., et al. "Towards smart biomanufacturing: a perspective on recent developments in industrial measurement and monitoring technologies for bio-based production processes." Journal of Industrial Microbiology & Biotechnology: Official Journal of the Society for Industrial Microbiology and Biotechnology 47.11 (2020): 947-964. DOI: https://doi.org/10.1007/s10295-020-02308-1
Gargalo, Carina L., et al. "Towards the development of digital twins for the bio-manufacturing industry." Digital twins: Tools and concepts for smart biomanufacturing (2021): 1-34. DOI: https://doi.org/10.1007/10_2020_142
Miller, John. "Beyond biotechnology: FDA regulation of nanomedicine." Colum. Sci. & Tech. L. Rev. 4 (2002): 1.
Brennan, Frank R., et al. "Current strategies in the non-clinical safety assessment of biologics: New targets, new molecules, new challenges." Regulatory Toxicology and Pharmacology 98 (2018): 98-107. DOI: https://doi.org/10.1016/j.yrtph.2018.07.009
Chen, Chao, and Genserik Reniers. "Risk assessment of processes and products in industrial biotechnology." Sustainability and Life Cycle Assessment in Industrial Biotechnology (2020): 255-279. DOI: https://doi.org/10.1007/10_2018_74
Pimenta, Cleila, et al. "Advanced therapies and regulatory framework in different areas of the globe: past, present, and future." Clinical Therapeutics 43.5 (2021): e103-e138. DOI: https://doi.org/10.1016/j.clinthera.2021.02.006
Li, Jing, et al. "Advances in synthetic biology and biosafety governance." Frontiers in bioengineering and biotechnology 9 (2021): 598087. DOI: https://doi.org/10.3389/fbioe.2021.598087
Cardwell, Michael. "The Release of Genetically Modified Organisms into the Environment: Public Concerns and Regulatory Responses." Environmental Law Review 4.3 (2002): 156-170. DOI: https://doi.org/10.1177/146145290200400303
Murashov, Vladimir, John Howard, and Paul Schulte. "Synthetic Biology Industry: Biosafety Risks to Workers." Synthetic Biology 2020: Frontiers in Risk Analysis and Governance (2020): 165-182. DOI: https://doi.org/10.1007/978-3-030-27264-7_8
Udugama, Isuru A., et al. "Perspectives on resource recovery from bio-based production processes: from concept to implementation." Processes 5.3 (2017): 48. DOI: https://doi.org/10.3390/pr5030048
Hashemi, Atieh. "CRISPR-Cas system as a genome engineering platform: applications in biomedicine and biotechnology." Current Gene Therapy 18.2 (2018): 115-124. DOI: https://doi.org/10.2174/1566523218666180221110627
Hong, Andrew. "CRISPR in personalized medicine: Industry perspectives in gene editing." Seminars in perinatology. Vol. 42. No. 8. WB Saunders, 2018. DOI: https://doi.org/10.1053/j.semperi.2018.09.008
Germino-Watnick, Paula, et al. "Hematopoietic stem cell gene-addition/editing therapy in sickle cell disease." Cells 11.11 (2022): 1843. DOI: https://doi.org/10.3390/cells11111843
Zarei, Ali, et al. "Creating cell and animal models of human disease by genome editing using CRISPR/Cas9." The journal of gene medicine 21.4 (2019): e3082. DOI: https://doi.org/10.1002/jgm.3082
Collins, Joseph H., and Eric M. Young. "Genetic engineering of host organisms for pharmaceutical synthesis." Current opinion in biotechnology 53 (2018): 191-200. DOI: https://doi.org/10.1016/j.copbio.2018.02.001
Andrianantoandro, Ernesto, et al. "Synthetic biology: new engineering rules for an emerging discipline." Molecular systems biology 2.1 (2006): 2006-0028. DOI: https://doi.org/10.1038/msb4100073
David, Florian, et al. "A perspective on synthetic biology in drug discovery and development—current impact and future opportunities." SLAS DISCOVERY: Advancing the Science of Drug Discovery 26.5 (2021): 581-603. DOI: https://doi.org/10.1177/24725552211000669
Li, Yujie, et al. "Advances in synthetic biology-based drug delivery systems for disease treatment." Chinese Chemical Letters (2024): 109576. DOI: https://doi.org/10.1016/j.cclet.2024.109576
Wang, Chi, et al. "Biosensor-based therapy powered by synthetic biology." Smart Materials in Medicine 4 (2023): 212-224. DOI: https://doi.org/10.1016/j.smaim.2022.10.003
Goetz, Laura H., and Nicholas J. Schork. "Personalized medicine: motivation, challenges, and progress." Fertility and sterility 109.6 (2018): 952-963. DOI: https://doi.org/10.1016/j.fertnstert.2018.05.006
Nair, Sunita R. "Personalized medicine: Striding from genes to medicines." Perspectives in clinical research 1.4 (2010): 146. DOI: https://doi.org/10.4103/2229-3485.71775
Ong, Frank S., et al. "Personalized medicine in ophthalmology: from pharmacogenetic biomarkers to therapeutic and dosage optimization." Journal of personalized medicine 3.1 (2013): 40-69. DOI: https://doi.org/10.3390/jpm3010040
Salari, Keyan, Hugh Watkins, and Euan A. Ashley. "Personalized medicine: hope or hype?." European heart journal 33.13 (2012): 1564-1570. DOI: https://doi.org/10.1093/eurheartj/ehs112
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a Attribution 4.0 International (CC BY 4.0).
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution - You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions - You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
